Additionally, TAMs increased PD-L1 expression in tumor-infiltrating myeloid cells via the COX-2/mPGES1/PGE2 pathway, leading to the exclusion of CD8+ T cells (Prima et al., 2017). This evidence concerns the gene CD8A and neoplasm.